Biochemical polymorphism of the growth hormone system proteins and its manifestations in human prostate cells

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biochemistry (Moscow)

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1134/S0006297910130043PMID 21417994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RACK1, A multifaceted scaffolding protein: Structure and function

  2011cited by this paper
• Neuroendocrine differentiation in prostate cancer.

  2009cited by this paper
• Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics

  2009cited by this paper
• Circulating insulin‐like growth factor peptides and prostate cancer risk: A systematic review and meta‐analysis

  2009cited by this paper
• The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology.

  2009cited by this paper
• Growth hormone isoforms.

  2009cited by this paper
• Global profiling of protease cleavage sites by chemoselective labeling of protein N-termini

  2009cited by this paper
• Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development.

  2009cited by this paper
• "Omics" data and levels of evidence for biomarker discovery.

  2009cited by this paper
• Genetic Variation in the SST Gene and its Receptors in Relation to Circulating Levels of Insulin-Like Growth Factor-I, IGFBP3, and Prostate Cancer Risk

  2009cited by this paper
• Ghrelin fluctuation, what determines its production?

  2009cited by this paper
• alpha-actinin-3 and performance.

  2009cited by this paper
• Genetic and plasma variation of insulin‐like growth factor binding proteins in relation to prostate cancer incidence and survival

  2009cited by this paper
• Copy number variation in human health, disease, and evolution.

  2009cited by this paper
• Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer.

  2009cited by this paper
• Regulation of growth hormone receptors in human prostate cancer cell lines.

  2009cited by this paper
• HPD: an online integrated human pathway database enabling systems biology studies

  2009cited by this paper
• Quantitative measures for the management and comparison of annotated genomes

  2009cited by this paper
• The evolution of protein domain families.

  2009cited by this paper
• A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.

  2009cited by this paper
• O‐Glycosylated 24 kDa human growth hormone has a mucin‐like biantennary disialylated tetrasaccharide attached at Thr‐60

  2009cited by this paper
• An interview with Dr. Giuseppe Viglietto on his highly cited paper published in Cell Cycle

  2009cited by this paper
• Elevated Blood Active Ghrelin and Unaltered Total Ghrelin and Obestatin Concentrations in Prostate Carcinoma

  2009cited by this paper
• The Prostate 69 : 1281 ^ 1291 ( 2009 ) Genetic andPlasmaVariationof Insulin-LikeGrowth FactorBinding Proteins in Relationto ProstateCancer Incidence and Survival

  2009cited by this paper
• The insulin-like growth factor-I receptor as an oncogene

  2009cited by this paper
• Growth hormone (GH)–releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus?

  2008cited by this paper
• Tools for analyzing and predicting N‐terminal protein modifications

  2008cited by this paper
• Growth hormone, IGF‐I and insulin and their abuse in sport

  2008cited by this paper
• Roles of unphosphorylated STATs in signaling

  2008cited by this paper
• Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis.

  2008cited by this paper
• Bridging structure with function: structural, regulatory, and developmental role of laminins.

  2008cited by this paper
• Ghrelin in the CNS: from hunger to a rewarding and memorable meal?

  2008cited by this paper
• Characterisation of the 5 kDa growth hormone isoform

  2008cited by this paper
• Ghrelin and prostate cancer.

  2008cited by this paper
• Evolution of the insulin receptor family and receptor isoform expression in vertebrates.

  2008cited by this paper
• RNA Editing of Androgen Receptor Gene Transcripts in Prostate Cancer Cells*

  2008cited by this paper
• Regulation of muscle mass by growth hormone and IGF‐I

  2008cited by this paper
• Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini.

  2008cited by this paper
• Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I.

  2008cited by this paper
• The Type 1 Insulin-Like Growth Factor Receptor Pathway

  2008cited by this paper
• MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets.

  2008cited by this paper
• Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression.

  2008cited by this paper
• Mesenchymal mechanisms in prostate organogenesis.

  2008cited by this paper
• Extent of N‐terminal modifications in cytosolic proteins from eukaryotes

  2008cited by this paper
• NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.

  2008cited by this paper
• Immunohistochemical Detection and Localization of Somatostatin Receptor Subtypes in Prostate Tissue from Patients with Bladder Outlet Obstruction

  2008cited by this paper
• A novel role of Shc adaptor proteins in steroid hormone-regulated cancers.

  2008cited by this paper
• Minireview: hormones and mammary cell fate--what will I become when I grow up?

  2008cited by this paper
• Interrelationships between dietary restriction, the IGF‐I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats

  2008cited by this paper
• The relationship between the GH/IGF-I axis and serum markers of bone turnover metabolism in healthy children.

  2007cited by this paper
• A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

  2007cited by this paper
• Biological & physiological aspects of action of insulin-like growth factor peptide family.

  2007cited by this paper
• Human growth hormone (GH1) gene polymorphism map in a normal-statured adult population

  2007cited by this paper
• Multiple mechanisms of growth hormone-regulated gene transcription.

  2007cited by this paper
• Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease

  2007cited by this paper
• Haplotype-Based Analysis of Common Variation in the Growth Hormone Receptor Gene and Prostate Cancer Risk

  2007cited by this paper
• Protein-tyrosine Phosphatase H1 Controls Growth Hormone Receptor Signaling and Systemic Growth*

  2007cited by this paper
• Altered adenosine-to-inosine RNA editing in human cancer.

  2007cited by this paper
• Novel insights in somatostatin receptor physiology.

  2007cited by this paper
• Insulin-Like Growth Factor-I Produced by Seminal Vesicles: Relationship to Intraepithelial Basal Cell Hyperplasia in the Prostate

  2007cited by this paper
• Genomic biomarkers, androgen pathway and prostate cancer.

  2007cited by this paper
• Regulation of MAPKs by growth factors and receptor tyrosine kinases.

  2007cited by this paper
• Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer.

  2006cited by this paper
• Insulin-like Growth Factor I Secreted from Prostate Stromal Cells Mediates Tumor-Stromal Cell Interactions of Prostate Cancer

  2006cited by this paper
• New insights into growth hormone action.

  2006cited by this paper
• Integrating Large-Scale Genotype and Phenotype Data

  2006cited by this paper
• The complexity of the mammalian transcriptome

  2006cited by this paper
• Prostate Cancer Risk in Relation to Selected Genetic Polymorphisms in Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-3, and Insulin-like Growth Factor-I Receptor

  2006cited by this paper
• A strong neuroprotective effect of the autonomous C‐terminal peptide of IGF‐1 Ec (MGF) in brain ischemia

  2005cited by this paper
• Regulation of cyclic nucleotides in the urinary tract.

  2005cited by this paper
• Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: Strong association of IRS1 G972R variant and cancer risk

  2005cited by this paper
• Obestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin's Effects on Food Intake

  2005cited by this paper
• Ghrelin: structure and function.

  2005cited by this paper
• The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues.

  2005cited by this paper
• Bioinformatics analysis of alternative splicing

  2005cited by this paper
• SINEs point to abundant editing in the human genome

  2005cited by this paper
• The Transcriptional Landscape of the Mammalian Genome

  2005cited by this paper
• Protein families and their evolution-a structural perspective.

  2005cited by this paper
• Central actions of somatostatin in the generation and control of breathing.

  2005cited by this paper
• Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.

  2004cited by this paper
• Synthetic Two-piece and Three-piece Split Inteins for Protein trans-Splicing*

  2004cited by this paper
• p63 and p73: roles in development and tumor formation.

  2004cited by this paper
• Transgenic Mice Reveal Novel Activities of Growth Hormone in Wound Repair, Angiogenesis, and Myofibroblast Differentiation*

  2004cited by this paper
• Interventions for sarcopenia and muscle weakness in older people.

  2004cited by this paper
• One gene, several messages. From multifunctional proteins to endogenous opiates

  2004cited by this paper
• GH1 splicing is regulated by multiple enhancers whose mutation produces a dominant-negative GH isoform that can be degraded by allele-specific small interfering RNA (siRNA).

  2004cited by this paper
• Genomics: Applications in Human Biology

  2004cited by this paper
• Under cover: causes, effects and implications of Hsp90‐mediated genetic capacitance

  2004cited by this paper
• Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines.

  2004cited by this paper
• Growth Hormone Secretion: Molecular and Cellular Mechanisms and In Vivo Approaches

  2004cited by this paper
• Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels.

  2004cited by this paper
• Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans.

  2003cited by this paper
• Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression.

  2003cited by this paper
• Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise.[see comment]

  2003cited by this paper
• Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions.

  2003cited by this paper
• The role of the growth hormone–insulin‐like growth factor axis in glucose homeostasis

  2003cited by this paper
• The insulin-like growth factor system.

  2003cited by this paper
• The Insulin-Like Growth Factor System

  2003cited by this paper
• A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin

  2003cited by this paper
• Prostate development and carcinogenesis.

  2003cited by this paper

• Efecto de la hormona de crecimiento sobre la proliferación y supervivencia de la línea celular de cáncer de próstata LNCaP

  2015cites this paper